By Glenn Dobson, CEO of The Drug Detection Agency (TDDA) The rapid expansion of the medicinal cannabis market in Australia and New Zealand raises significant concerns about workplace safety and public health. As someone deeply committed to maintaining drug-free and...
By Glenn Dobson, CEO of The Drug Detection Agency The recent media reports relating to the New Zealand court ruling following the tragic death of a worker at the Port of Auckland have underscored the critical role of leadership in workplace health and safety...
In this insightful article, Glenn Dobson discusses the critical need for employers to regularly update their drug and alcohol policies to ensure compliance with shifting legal frameworks and emerging workplace trends. With rising concerns around THC use and opioid...
Imperans Report to Provide Businesses with Actionable Health and Safety Information AUCKLAND, New Zealand, 04 November 2024 – The Drug Detection Agency (TDDA), New Zealand’s largest workplace drug testing provider, has launched the Imperans Report, its new quarterly...
October 2024 As the CEO of TDDA, it is critical to highlight the increasing safety risks surrounding the shift from CBD-dominant medicinal cannabis products to high-THC products in New Zealand and Australia. Originally, medicinal cannabis was intended to offer...
